First oral GLP-1 treatment for weight management - European Medicines Agency (EMA)

First oral GLP-1 treatment for weight management    European Medicines Agency (EMA) EMA backs Novo's Wegovy pill, first oral weight-loss drug for Europe    Reuters Novo’s Wegovy Obesity Pill Recommended for Approval in Europe    Bloomberg.com Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pill    CNBC How New Wegovy Obesity Trial Data At Novo Nordisk (CPSE:NOVO B) Has Changed Its Investment Story    Yahoo Finance

Original source: Google News